Efficacy of misoprostol as a treatment in abortions less than 12 weeks in a Maternal and Child Hospital of Honduras, 2019

Descripción del Articulo

Objective: To determine the efficacy of the use of misoprostol for the treatment of abortions less than 12 weeks of gestation in patients attended in the Gynecology and Obstetrics emergency room of a Maternal and Child Hospital of Honduras, 2019. Material and methods: Through a descriptive study cro...

Descripción completa

Detalles Bibliográficos
Autores: Martínez-Rodas, Oscar Ramón, Gonzáles-Castro, Gloria Mercedes, Carrasco-Cerrato, Doria Aracely, Parodi-Turcios, Karla Isabel
Formato: artículo
Fecha de Publicación:2020
Institución:Sociedad Materno Fetal
Repositorio:Revista Internacional de Salud Materno Fetal
Lenguaje:español
OAI Identifier:oai:ojs2.ojs.revistamaternofetal.com:article/147
Enlace del recurso:http://ojs.revistamaternofetal.com/index.php/RISMF/article/view/147
Nivel de acceso:acceso abierto
Materia:Control prenatal
Edad gestacional
Misoprostol
Aborto incompleto
id REVSMF_0fe5dee2d975bc4686fd20b26593b3b4
oai_identifier_str oai:ojs2.ojs.revistamaternofetal.com:article/147
network_acronym_str REVSMF
network_name_str Revista Internacional de Salud Materno Fetal
repository_id_str .
dc.title.none.fl_str_mv Efficacy of misoprostol as a treatment in abortions less than 12 weeks in a Maternal and Child Hospital of Honduras, 2019
Eficacia del misoprostol como tratamiento en abortos menores a 12 semanas en un Hospital Materno Infantil de Honduras, 2019
title Efficacy of misoprostol as a treatment in abortions less than 12 weeks in a Maternal and Child Hospital of Honduras, 2019
spellingShingle Efficacy of misoprostol as a treatment in abortions less than 12 weeks in a Maternal and Child Hospital of Honduras, 2019
Martínez-Rodas, Oscar Ramón
Control prenatal
Edad gestacional
Misoprostol
Aborto incompleto
title_short Efficacy of misoprostol as a treatment in abortions less than 12 weeks in a Maternal and Child Hospital of Honduras, 2019
title_full Efficacy of misoprostol as a treatment in abortions less than 12 weeks in a Maternal and Child Hospital of Honduras, 2019
title_fullStr Efficacy of misoprostol as a treatment in abortions less than 12 weeks in a Maternal and Child Hospital of Honduras, 2019
title_full_unstemmed Efficacy of misoprostol as a treatment in abortions less than 12 weeks in a Maternal and Child Hospital of Honduras, 2019
title_sort Efficacy of misoprostol as a treatment in abortions less than 12 weeks in a Maternal and Child Hospital of Honduras, 2019
dc.creator.none.fl_str_mv Martínez-Rodas, Oscar Ramón
Gonzáles-Castro, Gloria Mercedes
Carrasco-Cerrato, Doria Aracely
Parodi-Turcios, Karla Isabel
author Martínez-Rodas, Oscar Ramón
author_facet Martínez-Rodas, Oscar Ramón
Gonzáles-Castro, Gloria Mercedes
Carrasco-Cerrato, Doria Aracely
Parodi-Turcios, Karla Isabel
author_role author
author2 Gonzáles-Castro, Gloria Mercedes
Carrasco-Cerrato, Doria Aracely
Parodi-Turcios, Karla Isabel
author2_role author
author
author
dc.subject.none.fl_str_mv Control prenatal
Edad gestacional
Misoprostol
Aborto incompleto
topic Control prenatal
Edad gestacional
Misoprostol
Aborto incompleto
description Objective: To determine the efficacy of the use of misoprostol for the treatment of abortions less than 12 weeks of gestation in patients attended in the Gynecology and Obstetrics emergency room of a Maternal and Child Hospital of Honduras, 2019. Material and methods: Through a descriptive study cross-sectional, prospective study, in a sample of 155 patients treated at the Tegucigalpa Maternal and Child Hospital, from May to July 2019, through a probability sampling for convenience and using a structured survey. Obstetric, pathological history, misoprostol dose, time of effectiveness, side effects or complications, and prevalence of abortions were evaluated. Results: The average maternal age that presented the highest number of cases of abortion was 24 years, with 18-29 being the most affected age group, 73.55%. In the gynecological and obstetric antecedents identified, the first-born, primiparous, and with no history of abortions prevailed; while the pathological history such as hypertensive disorders, thyroid, type 2 diabetes mellitus and immunological diseases were not significant. Conclusion: The use of misoprostol in first trimester abortions is effective; its side effects do not produce significant complications and are tolerable; the first dose being the most effective and after one day after administration for the complete expulsion of the product.
publishDate 2020
dc.date.none.fl_str_mv 2020-04-12
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Artículos de investigación que van de acuerdo a la política editorial de la revista.
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://ojs.revistamaternofetal.com/index.php/RISMF/article/view/147
url http://ojs.revistamaternofetal.com/index.php/RISMF/article/view/147
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv http://ojs.revistamaternofetal.com/index.php/RISMF/article/view/147/181
dc.rights.none.fl_str_mv Derechos de autor 2020 Revista Internacional de Salud Materno Fetal
http://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Derechos de autor 2020 Revista Internacional de Salud Materno Fetal
http://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Sociedad Materno Fetal
publisher.none.fl_str_mv Sociedad Materno Fetal
dc.source.none.fl_str_mv Revista Internacional de Salud Materno Fetal; Vol. 6 Núm. 1 (2021); 11 - 17
International Journal of Mütterliche und fetale Gesundheit; Vol. 6 Núm. 1 (2021); 11 - 17
International Journal of Maternal and Fetal Health; Vol. 6 Núm. 1 (2021); 11 - 17
Revista Internacional de Saúde Materna e Fetal; Vol. 6 Núm. 1 (2021); 11 - 17
2519-9994
reponame:Revista Internacional de Salud Materno Fetal
instname:Sociedad Materno Fetal
instacron:RISMF
instname_str Sociedad Materno Fetal
instacron_str RISMF
institution RISMF
reponame_str Revista Internacional de Salud Materno Fetal
collection Revista Internacional de Salud Materno Fetal
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1846970190068187136
spelling Efficacy of misoprostol as a treatment in abortions less than 12 weeks in a Maternal and Child Hospital of Honduras, 2019Eficacia del misoprostol como tratamiento en abortos menores a 12 semanas en un Hospital Materno Infantil de Honduras, 2019Martínez-Rodas, Oscar RamónGonzáles-Castro, Gloria MercedesCarrasco-Cerrato, Doria AracelyParodi-Turcios, Karla IsabelControl prenatalEdad gestacionalMisoprostolAborto incompletoObjective: To determine the efficacy of the use of misoprostol for the treatment of abortions less than 12 weeks of gestation in patients attended in the Gynecology and Obstetrics emergency room of a Maternal and Child Hospital of Honduras, 2019. Material and methods: Through a descriptive study cross-sectional, prospective study, in a sample of 155 patients treated at the Tegucigalpa Maternal and Child Hospital, from May to July 2019, through a probability sampling for convenience and using a structured survey. Obstetric, pathological history, misoprostol dose, time of effectiveness, side effects or complications, and prevalence of abortions were evaluated. Results: The average maternal age that presented the highest number of cases of abortion was 24 years, with 18-29 being the most affected age group, 73.55%. In the gynecological and obstetric antecedents identified, the first-born, primiparous, and with no history of abortions prevailed; while the pathological history such as hypertensive disorders, thyroid, type 2 diabetes mellitus and immunological diseases were not significant. Conclusion: The use of misoprostol in first trimester abortions is effective; its side effects do not produce significant complications and are tolerable; the first dose being the most effective and after one day after administration for the complete expulsion of the product.Objetivo: Determinar la eficacia del uso de misoprostol para el tratamiento de abortos menores a 12 semanas de gestación en pacientes atendidas en la sala de emergencia de Ginecología y Obstetricia de un Hospital Materno Infantil de Honduras, 2019. Material y métodos: Mediante un estudio descriptivo transversal, prospectivo, en una muestra de 155 pacientes atendidas en el Hospital Materno Infantil de Tegucigalpa, durante Mayo a Julio del 2019, a través de un muestreo probabilístico por conveniencia y empleando una encuesta estructurada. Se evaluaron antecedentes obstétricos, patológicos, dosis de misoprostol, tiempo de efectividad, efectos secundarios o complicaciones y prevalencia de abortos. Resultados: La edad promedio materna que presentó mayor casos de aborto fue de 24 años, siendo 18-29 el grupo etario más afectado 73.55%. En los antecedentes gineco-obstétricos identificados prevalecieron las primigestas, primíparas y sin historia de abortos; mientras que los antecedentes patológicos como trastornos hipertensivos, tiroideos, diabetes mellitus tipo 2 y enfermedades inmunológicas no resultaron ser significativos. Conclusión: El uso del misoprostol en abortos del primer trimestre es efectivo; sus efectos secundarios no producen complicaciones significativas, y son tolerables; siendo la primera dosis la más efectiva y transcurriendo un día posterior a su administración para la expulsión completa del producto.Sociedad Materno Fetal2020-04-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtículos de investigación que van de acuerdo a la política editorial de la revista.application/pdfhttp://ojs.revistamaternofetal.com/index.php/RISMF/article/view/147Revista Internacional de Salud Materno Fetal; Vol. 6 Núm. 1 (2021); 11 - 17International Journal of Mütterliche und fetale Gesundheit; Vol. 6 Núm. 1 (2021); 11 - 17International Journal of Maternal and Fetal Health; Vol. 6 Núm. 1 (2021); 11 - 17Revista Internacional de Saúde Materna e Fetal; Vol. 6 Núm. 1 (2021); 11 - 172519-9994reponame:Revista Internacional de Salud Materno Fetalinstname:Sociedad Materno Fetalinstacron:RISMFspahttp://ojs.revistamaternofetal.com/index.php/RISMF/article/view/147/181Derechos de autor 2020 Revista Internacional de Salud Materno Fetalhttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:ojs2.ojs.revistamaternofetal.com:article/1472020-05-25T17:25:30Z
score 12.834301
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).